The Role of Butirprost® in Improving Antibiotic Treatment for Chronic Bacterial Prostatitis
Overview
Bacterial prostatitis (BP) is a common infection that causes pain and urinary issues in men, affecting their quality of life. Treatment usually involves antibiotics, but adding other supplements might improve results. This study focused on Butirprost® and its effects when used with antibiotics in patients with chronic bacterial prostatitis (CBP).
Study Details
Conducted at the University of Naples «Federico II» from March to July 2024, the study included patients with diagnosed prostatitis who had symptoms for over three months. Participants were divided into two groups:
- Group A: Received antibiotics plus Butirprost® (a combination of sodium hyaluronate and Plantago major) for one month.
- Group B: Received antibiotics only.
Results
Out of 60 patients (30 in each group), those in Group A experienced significant improvements in their symptoms at 15 and 30 days. This included:
- Less pain
- Improved urinary symptoms
- Better overall quality of life
Conclusion
Using Butirprost® alongside fluoroquinolones significantly enhanced symptom relief in patients with chronic bacterial prostatitis compared to using antibiotics alone.
Practical Solutions and Value
Clinical trials are essential for developing effective treatments. Our AI-driven platform, DocSym, offers a centralized knowledge base with ICD-11 standards and research to help clinicians improve patient care.
In today’s healthcare setting, efficiency is vital. Our mobile apps facilitate scheduling, treatment monitoring, and telemedicine, making patient management simpler and more effective.
By integrating AI, clinics can optimize workflows, enhance patient outcomes, and reduce reliance on paper processes. Visit aidevmd.com to learn more about our solutions.
